1. Home
  2. ASTI vs TPST Comparison

ASTI vs TPST Comparison

Compare ASTI & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Solar Technologies Inc.

ASTI

Ascent Solar Technologies Inc.

HOLD

Current Price

$6.55

Market Cap

34.3M

Sector

Technology

ML Signal

HOLD

TPST

Tempest Therapeutics Inc.

HOLD

Current Price

$2.12

Market Cap

30.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTI
TPST
Founded
2005
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.3M
30.9M
IPO Year
2014
2012

Fundamental Metrics

Financial Performance
Metric
ASTI
TPST
Price
$6.55
$2.12
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$11.00
AVG Volume (30 Days)
669.8K
260.6K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
70.23
N/A
EPS
N/A
N/A
Revenue
$10,398,149.00
$295,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
163.25
N/A
52 Week Low
$1.30
$1.50
52 Week High
$9.87
$12.22

Technical Indicators

Market Signals
Indicator
ASTI
TPST
Relative Strength Index (RSI) 62.57 55.47
Support Level $1.68 $1.50
Resistance Level $7.10 $2.49
Average True Range (ATR) 0.75 0.18
MACD 0.17 0.09
Stochastic Oscillator 72.47 75.00

Price Performance

Historical Comparison
ASTI
TPST

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is a solar technology company that manufactures and sells photovoltaic (PV) solar modules that are flexible, durable, and possess attractive power to weight and power to area performance. Its technology provides renewable power solutions to high-value production and specialty solar markets where traditional rigid solar panels are not suitable, including space power beaming, aerospace, satellites, near earth orbiting vehicles, fixed wing unmanned aerial vehicles (UAV), aquatic, terrestrial, and other weight-sensitive markets with transformational high quality, value added product applications. It operates in single PV segment that sells PV products and engineering services and currently, is selling it in North America.

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Share on Social Networks: